Author: OurCrowd

[Stellar Cyber in Business Wire] Stellar Cyber named to Futuriom 50 report for second consecutive year

Feb 1, 2023 |

ANTA CLARA, Calif.–(BUSINESS WIRE)–Stellar Cyber, the innovator of Open XDR, today announced that it has been named to the Futuriom 50 report for the second year in a row. Every year, analyst firm Futuriom names the strongest private companies in key markets for cloud and communications infrastructure, including cloud cybersecurity. Released today, the 2023 Futuriom 50 report includes Stellar Cyber for the second year in a row. Read more...

Read More

[Biolojic in Business Wire] First U.S. patient dosed in Aulos Bioscience’s Phase 1/2 clinical trial of AU-007, a novel IL-2 therapeutic for the treatment of solid tumors

Feb 1, 2023 |

LARKSPUR, Calif.–(BUSINESS WIRE)–Aulos Bioscience, an immuno-oncology company working to revolutionize cancer care through the development of potentially best-in-class IL-2 therapeutics, today announced that the first patient has been dosed in the United States in its Phase 1/2 clinical trial evaluating AU-007 for the treatment of solid tumors. Read...

Read More

[NT-Tao in PR Newswire] NT-Tao raises $22M Series A to ensure a secure, clean energy future with a compact and scalable nuclear fusion solution

Feb 1, 2023 | ,

TEL AVIV, Israel, Feb. 1, 2023 /PRNewswire/ — NT-Tao, the nuclear fusion energy company setting a new standard for the future of clean energy, today announced that it has raised a $22M Series A round led by Delek US – a Fortune 500 downstream energy company – and NextGear Ventures, with additional participation from Honda, OurCrowd and the Grantham Foundation, the lead investor in the company’s seed round. This new funding will enable NT-Tao to continue to scale its team, accelerate prototype developments in the pipeline and build its new research facility. The latest investment round brings NT-Tao’s total funding to $28M. Read more...

Read More